Clinical features of drug-induced Parkinsonism

被引:5
|
作者
Shiraiwa, Nobuko [1 ]
Tamaoka, Akira [2 ]
Ohkoshi, Norio [1 ]
机构
[1] Tsukuba Univ Technol, Dept Hlth Sci, Course Neurol, Tsukuba, Ibaraki, Japan
[2] Univ Tsukuba, Grad Sch Comprehens Human Sci, Dept Neurol, Tsukuba, Ibaraki, Japan
关键词
Drug-induced Parkinsonism; sulpiride; Parkinson's disease; malignant syndrome; oromandibular dyskinesia;
D O I
10.4081/ni.2018.7877
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Drug-induced Parkinsonism is often reversible after withdrawal of the causative drug. Its clinical course, however, is not well understood, as the majority of cases are caused by drugs prescribed by departments outside of neurology. We reviewed 21 cases of drug-induced parkinsonism for several factors, including age, sex, causative drug and reason for prescription, department by which it was prescribed, and outcome. The age at onset ranged from 40 to 87 years, with an average Hoehn and Yahr Scale score of 4, indicating severe disability. Sulpiride was the most commonly observed causative drug (71.4%). All causative drugs were prescribed in non-neurological departments and over one half were prescribed in non-psychiatric departments; most were prescribed to treat depression or abdominal discomfort. Ten patients (48%) were previously diagnosed with a neuromuscular disease, including cerebrovascular diseases and Parkinson's disease. Recovery was observed in 15 cases (71%) after withdrawal of the causative drug, but lingering symptoms were observed in the remaining cases. It is suggested that physicians should be more cautious of Parkinsonian side effects when prescribing such drugs.
引用
收藏
页码:103 / 106
页数:4
相关论文
共 50 条
  • [41] HLA ANTIGENS IN DRUG-INDUCED PARKINSONISM
    METZER, WS
    NEWTON, JEO
    STEELE, RW
    CLAYBROOK, M
    PAIGE, SR
    MCMILLAN, DE
    HAYS, S
    MOVEMENT DISORDERS, 1989, 4 (02) : 121 - 128
  • [42] Drug-induced parkinsonism: diagnosis and management
    Blanchet, Pierre J.
    Kivenko, Veronika
    JOURNAL OF PARKINSONISM AND RESTLESS LEGS SYNDROME, 2016, 6
  • [43] CALCIUM THERAPY IN DRUG-INDUCED PARKINSONISM
    LICHTIGFELD, FJ
    BRITISH JOURNAL OF PSYCHIATRY, 1965, 111 (470) : 197 - 198
  • [44] Drug-induced parkinsonism: diagnosis and treatment
    Conn, Hannah
    Jankovic, Joseph
    EXPERT OPINION ON DRUG SAFETY, 2024, 23 (12) : 1503 - 1513
  • [45] HEREDITARY PREDISPOSITION IN DRUG-INDUCED PARKINSONISM
    MYRIANTHOPOULOS, NC
    KURLAND, LT
    KURLAND, AA
    ARCHIVES OF NEUROLOGY, 1962, 6 (01) : 5 - &
  • [46] AMELIORATION OF DRUG-INDUCED PARKINSONISM BY ECT
    ANANTH, J
    SAMRA, D
    KOLIVAKIS, T
    AMERICAN JOURNAL OF PSYCHIATRY, 1979, 136 (08): : 1094 - 1094
  • [47] Drug-induced parkinsonism in hospitalized patients
    Ponte, M.
    Merletti, P. F. Garcia
    Wachs, A.
    Noel, A.
    MOVEMENT DISORDERS, 2009, 24 : S66 - S66
  • [48] Drug-induced Parkinsonism. Clinical aspects compared with Parkinson disease
    Errea-Abad, JM
    Ara-Callizo, JR
    Aibar-Remon, C
    REVISTA DE NEUROLOGIA, 1998, 27 (155) : 35 - 39
  • [49] A clinical study of biochemical markers in Parkinson disease, and drug-induced Parkinsonism
    Kodama, M.
    Katoh, S.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 365 - 365
  • [50] THE CLINICAL-ASSOCIATION OF TARDIVE-DYSKINESIA AND DRUG-INDUCED PARKINSONISM
    WOLF, ME
    CHEVESICH, J
    LEHRER, E
    MOSNAIM, AD
    BIOLOGICAL PSYCHIATRY, 1983, 18 (10) : 1181 - 1188